GlassScriptPhysician profile
Merson Samuel
NPI 1174643654
$1,429.72
in general payments reported to CMS, 2019-2025
21 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $504 · 2022: $303 · 2023: $187 · 2024: $136 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $265.35 | 2021-2024 | Korlym |
| Xeris Pharmaceuticals, INC. | $240.75 | 2024-2025 | Gvoke Hypopen |
| Vifor Pharma, INC. | $145.58 | 2021 | |
| Alnylam Pharmaceuticals INC. | $126.75 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $105.07 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $84.88 | 2023 | Xarelto |
| Amneal Pharmaceuticals LLC | $63.29 | 2021-2022 | |
| Amgen INC. | $57.18 | 2021 | |
| Medtronic, INC. | $54.44 | 2021-2024 | Minimed 780g |
| Alexion Pharmaceuticals, INC. | $40.42 | 2023-2024 | Strensiq |
| Abbott Laboratories | $25.00 | 2021 | |
| Dexcom, INC. | $24.01 | 2022 | |
| Advanced Oxygen Therapy INC. | $23.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.61 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.91 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.66 | 2023 | |
| Janssen Scientific Affairs, LLC | $22.13 | 2022 | |
| Althera Pharmaceuticals LLC | $21.88 | 2021 | |
| Zealand Pharma US, INC. | $21.00 | 2021 | |
| Pfizer INC. | $20.03 | 2022 | |
| Insulet Corporation | $19.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merson Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.